Basel Medical Group Ltd
BMGL
$4.33
-$0.1094-2.46%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.46M | 7.36M | 7.26M | 7.19M | 7.11M |
| Total Other Revenue | 14.50K | 23.90K | 33.30K | 33.50K | 33.70K |
| Total Revenue | 7.47M | 7.39M | 7.30M | 7.23M | 7.14M |
| Cost of Revenue | 4.37M | 3.94M | 3.50M | 3.79M | 4.08M |
| Gross Profit | 3.10M | 3.45M | 3.79M | 3.43M | 3.07M |
| SG&A Expenses | 520.90K | 649.60K | 777.70K | 783.00K | 788.20K |
| Depreciation & Amortization | 392.30K | 383.00K | 373.20K | 390.80K | 407.50K |
| Other Operating Expenses | 603.80K | 441.30K | 277.30K | 336.90K | 395.00K |
| Total Operating Expenses | 5.88M | 5.41M | 4.93M | 5.30M | 5.67M |
| Operating Income | 1.59M | 1.97M | 2.36M | 1.92M | 1.48M |
| Income Before Tax | 1.78M | 2.18M | 2.58M | 2.08M | 1.58M |
| Income Tax Expenses | 245.60K | 481.00K | 718.10K | 489.50K | 260.90K |
| Earnings from Continuing Operations | 1.54 | 1.70 | 1.87 | 1.59 | 1.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.54M | 1.70M | 1.87M | 1.59M | 1.32M |
| EBIT | 1.59M | 1.97M | 2.36M | 1.92M | 1.48M |
| EBITDA | 1.61M | 2.00M | 2.39M | 1.94M | 1.50M |
| EPS Basic | 0.09 | 0.10 | 0.11 | 0.10 | 0.08 |
| Normalized Basic EPS | 0.07 | 0.08 | 0.10 | 0.08 | 0.06 |
| EPS Diluted | 0.09 | 0.10 | 0.11 | 0.10 | 0.08 |
| Normalized Diluted EPS | 0.07 | 0.08 | 0.10 | 0.08 | 0.06 |
| Average Basic Shares Outstanding | 65.00M | 65.00M | 65.00M | 65.00M | 65.00M |
| Average Diluted Shares Outstanding | 65.00M | 65.00M | 65.00M | 65.00M | 65.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |